HK1199398A1 - New pediatric uses of cabazitaxel - Google Patents

New pediatric uses of cabazitaxel

Info

Publication number
HK1199398A1
HK1199398A1 HK14112919.7A HK14112919A HK1199398A1 HK 1199398 A1 HK1199398 A1 HK 1199398A1 HK 14112919 A HK14112919 A HK 14112919A HK 1199398 A1 HK1199398 A1 HK 1199398A1
Authority
HK
Hong Kong
Prior art keywords
cabazitaxel
pediatric uses
new pediatric
new
pediatric
Prior art date
Application number
HK14112919.7A
Other languages
English (en)
Chinese (zh)
Inventor
S Sidhu Sukhvinder
Patricia Vrignaud
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HK1199398A1 publication Critical patent/HK1199398A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
HK14112919.7A 2012-02-10 2014-12-24 New pediatric uses of cabazitaxel HK1199398A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305151 2012-02-10
EP12306352 2012-10-30
PCT/EP2013/052518 WO2013117683A1 (en) 2012-02-10 2013-02-08 New pediatric uses of cabazitaxel

Publications (1)

Publication Number Publication Date
HK1199398A1 true HK1199398A1 (en) 2015-07-03

Family

ID=47714075

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112919.7A HK1199398A1 (en) 2012-02-10 2014-12-24 New pediatric uses of cabazitaxel

Country Status (21)

Country Link
US (1) US20140350273A1 (xx)
EP (1) EP2811996A1 (xx)
JP (1) JP2015509929A (xx)
KR (1) KR20140129091A (xx)
CN (1) CN104334172A (xx)
AU (1) AU2013217964A1 (xx)
BR (1) BR112014019675A2 (xx)
CA (1) CA2864029A1 (xx)
CL (1) CL2014002118A1 (xx)
CO (1) CO7030963A2 (xx)
CR (1) CR20140374A (xx)
EA (1) EA201491506A1 (xx)
GT (1) GT201400173A (xx)
HK (1) HK1199398A1 (xx)
IL (1) IL234015A0 (xx)
MX (1) MX2014009610A (xx)
NZ (1) NZ628565A (xx)
PH (1) PH12014501794A1 (xx)
SG (1) SG11201404712UA (xx)
WO (1) WO2013117683A1 (xx)
ZA (1) ZA201405815B (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
CN102781237A (zh) * 2009-11-23 2012-11-14 天蓝制药公司 用于传递治疗剂的基于环糊精的聚合物

Also Published As

Publication number Publication date
US20140350273A1 (en) 2014-11-27
IL234015A0 (en) 2014-09-30
EA201491506A1 (ru) 2014-12-30
KR20140129091A (ko) 2014-11-06
ZA201405815B (en) 2015-11-25
SG11201404712UA (en) 2014-09-26
BR112014019675A2 (pt) 2017-07-11
CO7030963A2 (es) 2014-08-21
NZ628565A (en) 2016-03-31
CA2864029A1 (en) 2013-08-15
CL2014002118A1 (es) 2015-06-26
CR20140374A (es) 2014-12-01
GT201400173A (es) 2015-08-13
MX2014009610A (es) 2015-09-25
WO2013117683A1 (en) 2013-08-15
CN104334172A (zh) 2015-02-04
EP2811996A1 (en) 2014-12-17
AU2013217964A1 (en) 2014-08-28
PH12014501794A1 (en) 2014-11-24
JP2015509929A (ja) 2015-04-02

Similar Documents

Publication Publication Date Title
GB2526932B (en) Administration of web page
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
EP2864479A4 (en) MODULATION OF UBE3A-ATS EXPRESSION
ZA201406082B (en) Use of ccr3-inhibitors
EP2826473A4 (en) NEW USE OF PATCHOULOL
HK1209767A1 (en) Purification of iduronate-2-sulfatase -2-
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
GB2502767B (en) Cannula
EP2807551A4 (en) ROAD CHARACTERISTICS OF NOTES
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
IL236312A0 (en) Preparation of 18f-flucyclobin
GB201222832D0 (en) Manufacture of hollow parts
EP2881113A4 (en) NEW APPLICATION OF POGOSTONE
HK1207282A1 (en) Nasal dilator
EP2892529A4 (en) USES OF (-) - PERHEXILINE
EP2932972A4 (en) NEW CATALPOL APPLICATION
PL2934593T3 (pl) Kompozycja kabazytakselu
HUE036419T2 (hu) Légzõszervi depresszió kezelése
GB201207907D0 (en) Treatment of depression
EP2887938A4 (en) PROCESS FOR PREPARING TECOVIRIMAT
HK1199398A1 (en) New pediatric uses of cabazitaxel
GB201203391D0 (en) Medico-surgical assemblies
TWM433525U (en) Structure of calorifier
IL233446A0 (en) Polymorphic forms of paramphenel
GB201222952D0 (en) Treatent of cancer